Global /China /Healthcare /Drug Manufacturers - General /301263

Guangdong Taienkang Pharmaceutical Co., Ltd.

301263

• SHE: 301263 • Delayed

28.65CNY -0.3%

4.24 USD

As of 18 June 2026, Guangdong Taienkang Pharmaceutical Co., Ltd. has a market cap of $1.8B USD, ranking #7600 globally and #1909 in China. It ranks #619 in the Healthcare sector, and #243 in the Drug Manufacturers - General industry.

Global Rank

7600

Country Rank

1909

Sector Rank

619

Industry Rank

243

Key Stats

Market Cap

$1.8BUSD

12.13B CNY

Enterprise Value

$1.77BUSD

11.99B CNY

Revenue (TTM)

$99.8MUSD

674.49M CNY

EBITDA (TTM)

$9.55MUSD

64.56M CNY

Net Income (TTM)

$3.45MUSD

23.29M CNY

EBITDA Margin

9.6%

Profit Margin

3.5%

PE Ratio

521.0

PS Ratio

18.0

PB Ratio

6.7

EV/EBITDA

181.2

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Hanjie Zheng open_in_new

Employees

1,081

Founded

1999

Website

tai-kang.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.3%	-3.1%	11%	-14%	-8.6%	-0.9%	48%	52%	41%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	301263 广东泰恩康医药股份有限公司 Class A ISIN: CNE1000058X0 Shares Out.: Shares Outstanding: 361.921M¹ Shares Float: 238.817M² TV: TradingView: SZSE: 301263 SA: Stock Analysis: SHE: 301263 YF: Yahoo Finance: 301263.SZ GF: Google Finance: SHE: 301263 BA: Barron's: 301263 MS: Morningstar: XSHE: 301263	28.65 CNY	TV: TradingView: SZSE: 301263 SA: Stock Analysis: SHE: 301263 YF: Yahoo Finance: 301263.SZ GF: Google Finance: SHE: 301263 BA: Barron's: 301263 MS: Morningstar: XSHE: 301263

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Guangdong Taienkang Pharmaceutical Co., Ltd.

Guangdong Taienkang Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company offers various products covering various therapeutic areas, including sexual health medicines, ophthalmic medicines, gastrointestinal medicines, Chinese patent medicines and external medicines, and sanitary materials in the form of tablets, pills, injections, and essential oils; medical technology and technology transfer services; and medical devices. It also operates as an agent for pharmaceutical products; and offers medical and sanitary materials, masks, sutures, surgical staplers, vascular clips and clip appliers, etc., as well as non-prescription drugs. The company was formerly known as Shantou Taikang Pharmaceutical Co., Ltd. and changed its name to Guangdong Taienkang Pharmaceutical Co., Ltd. in June 2006. Guangdong Taienkang Pharmaceutical Co., Ltd. was founded in 1999 and is headquartered in Shantou, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.99B 364.89B CNY 3K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.77B 336.36B CNY 3K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 1K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 947%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.56B 111.89B CNY 822%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 792%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 42K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 30K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 20K%	97.4	United States
Roche Holding AG SIX: RO	$321.45B 256.25B CHF 18K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$287.52B 215.59B GBP 16K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.59B 218.9B CHF 15K%	20.5	Switzerland

chevron_leftBack